Cargando…

Development of a Prognostic Nomogram for Patients with Lung Adenocarcinoma in the Stages I, II, and III Based on Immune Scores

BACKGROUND: Immunotherapy has significantly changed the treatment prospects of non-small cell lung cancer (NSCLC). However, there is no report based on immune score to predict the overall survival (OS) of lung adenocarcinoma (LUAD) in the stages I, II, and III. Therefore, this study aimed to investi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Hui, Zhang, Jian-Fang, Li, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627271/ https://www.ncbi.nlm.nih.gov/pubmed/34849011 http://dx.doi.org/10.2147/IJGM.S337934

Ejemplares similares

Development of an Oncogenic Driver Alteration Associated Immune-Related Prognostic Model for Stage I-II Lung Adenocarcinoma
por: Xu, Jian-Zhao, et al.
Publicado: (2021)

Identification of a methylomics-associated nomogram for predicting overall survival of stage I–II lung adenocarcinoma
por: Wang, Heng, et al.
Publicado: (2021)

Characteristics and Prognostic Nomogram for Primary Lung Lepidic Adenocarcinoma
por: Tang, Hui, et al.
Publicado: (2022)

Development and validation of a nomogram for patients with stage II/III gastric adenocarcinoma after radical surgery
por: Wang, Lei, et al.
Publicado: (2022)

Prognostic Nomograms Based on Ground Glass Opacity and Subtype of Lung Adenocarcinoma for Patients with Pathological Stage IA Lung Adenocarcinoma
por: Zhai, Wenyu, et al.
Publicado: (2021)

Hallmark guided identification and characterization of a novel immune-relevant signature for prognostication of recurrence in stage I–III lung adenocarcinoma
por: Zhang, Yongqiang, et al.
Publicado: (2022)

Nomogram for predicting overall survival in stage II‐III colorectal cancer
por: Liu, Jungang, et al.
Publicado: (2020)

Development and Validation of a Nomogram for Predicting the Risk of Bell's Stage II/III Necrotizing Enterocolitis in Neonates Compared to Bell's Stage I
por: Song, Shuting, et al.
Publicado: (2022)

Development and validation of an individualized immune prognostic model in stage I–III lung squamous cell carcinoma
por: Yang, Qi-Fan, et al.
Publicado: (2021)

Development and Validation of a Prognostic Nomogram for Lung Adenocarcinoma: A Population-Based Study
por: Xie, Bin, et al.
Publicado: (2022)

The Characteristics and Nomogram for Primary Lung Papillary Adenocarcinoma
por: Zhang, Yuqian, et al.
Publicado: (2020)

A prognostic nomogram for predicting recurrence-free survival of stage I–III colon cancer based on immune-infiltrating Treg-related genes
por: Xu, Longwen, et al.
Publicado: (2023)

Prognostic evaluation of stage I lung adenocarcinoma based on systematic inflammatory response
por: Qian, Jia-Yi, et al.
Publicado: (2023)

A nomogram-based immune-serum scoring system predicts overall survival in patients with lung adenocarcinoma
por: Huang, Qiujuan, et al.
Publicado: (2021)

A Nomogram Model for Predicting Recurrence of Stage I–III Endometrial Cancer Based on Inflammation-Immunity-Nutrition Score (IINS) and Traditional Classical Predictors
por: Jiang, Peng, et al.
Publicado: (2022)

Prognostic nomogram based on immune scores for breast cancer patients
por: Wang, Ju, et al.
Publicado: (2019)

The Prognostic Role and Nomogram Establishment of a Novel Prognostic Score Combining with Fibrinogen and Albumin Levels in Patients with WHO Grade II/III Gliomas
por: Jia, Tianshu, et al.
Publicado: (2021)

A prognostic nomogram for stage II/III rectal cancer patients treated with neoadjuvant chemoradiotherapy followed by surgical resection
por: Lin, Yanfei
Publicado: (2022)

Establishment and validation of a prognostic nomogram for patients with early-onset stage I–II colon cancer
por: Li, Dongdong
Publicado: (2023)

Radiomics nomogram for prediction disease-free survival and adjuvant chemotherapy benefits in patients with resected stage I lung adenocarcinoma
por: Xie, Dong, et al.
Publicado: (2020)

Prognostic significance of preoperative prognostic immune and nutritional index in patients with stage I–III colorectal cancer
por: Xie, Hailun, et al.
Publicado: (2022)

Prognostic Value of E-cadherin-, CD44-, and MSH2-associated Nomograms in Patients With Stage II and III Colorectal Cancer
por: Qu, Jinmiao, et al.
Publicado: (2017)

Development and validation of a prognostic nomogram for predicting early recurrence after curative resection of stage II/III gastric cancer
por: Ma, Min, et al.
Publicado: (2019)

Development and validation of prognostic nomograms based on De Ritis ratio and clinicopathological features for patients with stage II/III colorectal cancer
por: Fu, Jinming, et al.
Publicado: (2023)

An Innovative Immune Score-Based Prognostic Nomogram for Patients with Cervical Cancer
por: Qi, Xingling, et al.
Publicado: (2020)

Identification of Prognostic Model Based on Immune-Related LncRNAs in Stage I-III Non-Small Cell Lung Cancer
por: Li, Qiaxuan, et al.
Publicado: (2021)

Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data
por: Chen, Jian, et al.
Publicado: (2021)

Survival nomograms for stage III colorectal cancer
por: Li, Chenglong, et al.
Publicado: (2018)

Prognostic value of immune related genes in lung adenocarcinoma
por: Wang, Han, et al.
Publicado: (2020)

Serum miRNA expression profile as a prognostic biomarker of stage II/III colorectal adenocarcinoma
por: Li, Jialu, et al.
Publicado: (2015)

Pre-treatment platelet counts as a prognostic and predictive factor in stage II and III rectal adenocarcinoma
por: Steele, Morgan, et al.
Publicado: (2017)

Prognostic value of MMP9 activity level in resected stage I B lung adenocarcinoma
por: Yu, Yongfeng, et al.
Publicado: (2016)

A prognostic nomogram for lung adenocarcinoma based on immune-infiltrating Treg-related genes: from bench to bedside
por: Wang, Xiaofei, et al.
Publicado: (2021)

Assessing the Prognostic Capability of Immune-Related Gene Scoring Systems in Lung Adenocarcinoma
por: Liu, Wenhao, et al.
Publicado: (2022)

Novel prognostic model for stratifying survival in stage I lung adenocarcinoma patients
por: Liu, Di-Han, et al.
Publicado: (2019)

Development and validation of a nomogram for predicting overall survival in patients with stage III-N2 lung adenocarcinoma based on the SEER database
por: Zhang, Shengchao, et al.
Publicado: (2023)

Blood parameters score predicts long-term outcomes in stage II-III gastric cancer patients
por: Lin, Jian-Xian, et al.
Publicado: (2019)

Prognostic Value of Inflammatory Biomarkers in Patients With Stage I Lung Adenocarcinoma Treated With Surgical Dissection
por: Shen, Yu-Jia, et al.
Publicado: (2021)

Clinical predictors of treatment efficacy and a prognostic nomogram in patients with lung adenocarcinoma receiving immune checkpoint inhibitors: a retrospective study
por: Hu, Fang, et al.
Publicado: (2022)

Impact of Postoperative Naples Prognostic Score to Predict Survival in Patients with Stage II–III Colorectal Cancer
por: Park, Su Hyeong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b52kot2jffj55s9uq4pekda919